PetMed Express, Inc. to Participate in the Sidoti Micro Cap Conference
Get Alerts PETS Hot Sheet
Join SI Premium – FREE
DELRAY BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024 virtually.
Sandra Campos, CEO and President, will meet with investors and present at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the “Events & Presentations” section of PetMed’s investor relations website at https://investors.petmeds.com or directly here.
About PetMed Express, Inc.
Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer with expert pharmacists and licenses across fifty states, PetMeds.com and PetCareRx.com deliver top branded pharmaceuticals, generics, compounded prescription medications and OTC supplements and vitamins that help pets live longer, healthier lives. Leveraging telehealth and insurance partnerships, they offer unparalleled value and convenience that enhance wellness and longevity for dogs, cats, and horses. PetMeds and PetCareRx provides essential pet health offerings through their websites, www.PetMeds.com and www.PetCareRx.com.
Investor Contact:
ICR, LLC
John Mills
(646) 277-1254
Reed Anderson
(646) 277-1260
Source: PetMed Express, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Efficient LED Driver Driving Up to 4 RGB Dots While Extending the Device Battery Life
- OrbitX Targets Southeast Asian Retail Commerce with Stablecoin QR Payment Deployment in Vietnam and the Philippines
- Erasure of Healthcare Stigma for Modern Viral Epidemics : the Data-Driven Approach of 26Health Featured on "All Access hosted by Andy Garcia"
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share